Active, Not Recruiting
Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors
NCT03252938
- Conditions
- Abdominal Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +12 more
- Locations
-
- Helios Klinikum Bad Saarow Bad Saarow, Germany
- Kliniken der Stadt Köln gGmbH, Studienzentrum der Lungenklinik, Krankenhaus Merheim Cologne, Germany
- Universitätsklinikum Essen Essen, Germany
- Agaplesion Markus Krankenhaus Frankfurter Diakonie Kliniken gGmbH Frankfurt, Germany